Oral antiviral treatments for COVID-19: opportunities and challenges

New paper by USERN Junior Ambassadors

1️⃣ Presents the potential pharmaceutical antiviral targets, including various host-based targets and viral-based targets
2️⃣ Characterizes the first-generation anti-SARS-CoV-2 oral drugs (nirmatrelvir/ritonavir and molnupiravir)
3️⃣ Summarizes the clinical progress of other oral antivirals for use in COVID-19
4️⃣ Discusses ethical issues in such clinical trials
5️⃣ Presents challenges associated with the use of oral antivirals in clinical practice

🌐 Source: https://link.springer.com/article/10.1007/s43440-022-00388-7

#Paper
#UJA

@usern_net